Items where authors include "Thieblemont, C."

Article

Rejeski, K., Subklewe, M. orcid.org/0000-0003-3905-0251, Aljurf, M. et al. (34 more authors) (2023) Immune effector cell-associated hematotoxicity (ICAHT): EHA/EBMT consensus grading and best practice recommendations. Blood Journal. 2023020578. ISSN 0006-4971

Katz, D.A., Morris, J.D., Chu, M.P. et al. (17 more authors) (2022) Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL. Leukemia & Lymphoma, 63 (9). pp. 2063-2073. ISSN 1042-8194

Hayden, P.J., Roddie, C., Bader, P. et al. (33 more authors) (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of Oncology, 33 (3). pp. 259-275. ISSN 0923-7534